Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Assessment of the Effectiveness of Direct-Acting Antiviral Therapy in Patients with Hepatitis C: A Follow-Up Analysis in Yazd, Iran
- Irandegani Z. , et al.
2. Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country
- Tantuoyir M.M. , et al.
3. Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study
- Tasavon Gholamhoseini M. , et al.
4. The Treatment of Ledipasvir/Sofosbuvir in Patients with Chronic Hepatitis C Virus: The Results of Five-year Follow-up
- Pekgöz M. , et al.
5. Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders
- Sharafi H. , et al.
6. A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- To middle-income setting
- Hariri S. , et al.
7. Effectiveness of generic direct-acting agents for the treatment of hepatitis C: Systematic review and meta-analysis
- Perazzo H. , et al.
8. Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study
- Sharafi H. , et al.
9. The Rising Threat of Hepatocellular Carcinoma in the Middle East and North Africa Region: Results From Global Burden of Disease Study 2017
- Sharafi H. , et al.
10. Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank
- Sharafi H. , et al.
11. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting
- Sharafi H. , et al.
12. Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBank
- Sharafi H. , et al.
13. Treatment of HCV infection with direct-acting antiviral agents in patients with HIV/HCV co-infection: A systematic review
- Alavian S.M. , et al.
14. Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?
- Sharafi H. , et al.
15. Comment on 'Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: The ANRS HC32 QUATTRO study'
- Alavian S. , et al.
16. Seroprevalence of hepatitis C virus among blood donors in middle eastern countries: A systematic review and meta-analysis
- Ghaderi-Zefrehi H. , et al.
17. Update on recommendations for the clinical management of hepatitis C in Iran 2017
- Alavian S.M. , et al.